Compare Ravinder Heights with Similar Stocks
Dashboard
Poor Management Efficiency with a low ROE of 2.66%
- The company has been able to generate a Return on Equity (avg) of 2.66% signifying low profitability per unit of shareholders funds
With ROE of 10.3, it has a Expensive valuation with a 0.7 Price to Book Value
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
Ravinder Heights for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Ravinder Heights Ltd Valuation Shifts Signal Price Attractiveness Concerns
Ravinder Heights Ltd, a micro-cap player in the realty sector, has seen a notable shift in its valuation parameters, moving from a fair to an expensive rating. Despite a recent surge in share price and strong long-term returns, the company’s price-to-earnings and price-to-book ratios now suggest a premium valuation compared to historical averages and peer benchmarks, prompting a downgrade in its investment grade to Sell.
Read full news article
Ravinder Heights Ltd is Rated Sell
Ravinder Heights Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article Announcements 
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
09-Apr-2026 | Source : BSEFormat of Initial Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details |
| 1 | Name of Company | Ravinder Heights Ltd |
| 2 | CIN NO. | L70109PB2019PLC049331 |
| 3 | Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) | 0.00 |
| 4 | Highest Credit Rating during the previous FY | NA |
| 4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | Not Applicable |
| 5 | Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework | BSE |
Designation: Company Secretary and Compliance Officer
EmailId: info@ravinderheights.com
Designation: Chief Financial Officer
EmailId: info@ravinderheights.com
Date: 09/04/2026
Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09-Apr-2026 | Source : BSECertificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the Quarter ended 31st March 2026
Closure of Trading Window
25-Mar-2026 | Source : BSEThis is to inform you that the Trading Window for Trading in Securities of the Company will remain closed from April 01 2026 till 48 hours after announcement of Audited Standalone and Consolidated Financial Results for the Quarter and Year ended March 31 2026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Sunanda Jain (74.74%)
Serum Institute Of India Private Limited (4.58%)
16.38%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -63.62% vs 42,215.38% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -68.70% vs 7,767.31% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 18,280.00% vs -6.25% in Sep 2024
Growth in half year ended Sep 2025 is 8,472.34% vs -135.00% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 16,979.55% vs -6.38% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 3,299.38% vs 11.96% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -8.06% vs -94.85% in Mar 2024
YoY Growth in year ended Mar 2025 is -18.14% vs -134.85% in Mar 2024







